— Know what they know.
Not Investment Advice

OMER NASDAQ

Omeros Corporation
1W: -9.9% 1M: -10.6% 3M: -0.7% YTD: -27.0% 1Y: +263.5% 3Y: +124.8% 5Y: -34.3%
$11.46
-0.50 (-4.18%)
 
Weekly Expected Move ±8.0%
$10 $11 $12 $13 $14
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 35 · $829.4M mcap · 70M float · 1.68% daily turnover · Short 64% of daily vol

Balance Sheet Trends

Total Assets
$277M -26.8% ▼
5Y CAGR: +15.1%
Total Liabilities
$460M +14.0% ▲
5Y CAGR: +13.3%
Shareholders Equity
-$183M -630.9% ▼
Cash & Investments
$90M -47.6% ▼
5Y CAGR: +8.2%
Total Debt
$207M -42.7% ▼
5Y CAGR: +1.3%
Net Debt
$204M -42.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$11M$101M$11M$7M$3M
Short-Term Investments$124M$56M$184M$165M$87M
Cash & ST Investments$135M$157M$195M$172M$90M
Net Receivables$4M$82M$242M$7M$37M
Inventory$1M$0$0$0$0
Other Current Assets$681K$67K$6M$31M$7M
Total Current Assets$151M$248M$443M$218M$134M
Property, Plant & Equip.$28M$30M$23M$21M$18M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$2M$141M$124M$140M$125M
Total Non-Current Assets$30M$171M$148M$160M$143M
Total Assets$181M$419M$591M$378M$277M
— Liabilities —
Accounts Payable$4M$13M$6M$8M$6M
Short-Term Debt$0$0$94M$9M$21M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$4M$4M$8M$0$30M
Total Current Liabilities$37M$52M$136M$53M$80M
Long-Term Debt$236M$313M$221M$330M$167M
Other Non-Current Liab.$0$1M$126M$2M$200M
Total Non-Current Liabilities$265M$344M$369M$350M$380M
Total Liabilities$302M$395M$505M$403M$460M
— Equity —
Common Stock$616K$626K$628K$611K$580K
Retained Earnings-$873M-$683M-$636M-$754M-$910M
Accumulated OCI$0$0$0-$0$0
Total Stockholders Equity-$121M$24M$86M-$25M-$183M
Total Liabilities & Equity$181M$419M$591M$378M$277M
— Key Metrics —
Total Debt$269M$348M$342M$362M$207M
Net Debt$258M$247M$331M$354M$204M
Total Investments$124M$56M$184M$165M$87M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms